Piramal Pharma Limited Discloses Contact Details of Key Managerial Personnel
Piramal Pharma Limited has submitted the contact details of its Key Managerial Personnel (KMP) to BSE Limited and National Stock Exchange of India Limited on April 29, 2026. The disclosure was made in compliance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The contact information is intended for determining materiality of events or information and for making disclosures to the stock exchanges under Regulation 30. The company provided details of two Key Managerial Personnel: Mr. Vivek Valsaraj, who serves as Chief Financial Officer and Whole-Time Director, and Mr. Maneesh Sharma, who holds the position of Company Secretary and Compliance Officer. The filing was digitally signed by Vivek Valsaraj on April 29, 2026, at 15:43:52 IST.
*this image is generated using AI for illustrative purposes only.
Piramal Pharma Limited has submitted the contact details of its Key Managerial Personnel (KMP) to BSE Limited and National Stock Exchange of India Limited on April 29, 2026. The disclosure was made in compliance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The contact information is intended for determining materiality of events or information and for making disclosures to the stock exchanges under Regulation 30.
Key Managerial Personnel Details
The company provided the following contact details of its Key Managerial Personnel:
| Sr. No. | Name of KMP | Designation of KMP | Email ID of KMP |
|---|---|---|---|
| 1. | Mr. Vivek Valsaraj | Chief Financial Officer | vivek.valsaraj@piramal.com |
| 2. | Mr. Maneesh Sharma | Company Secretary and Compliance Officer | maneesh.sharma2@piramal.com |
Filing Details
The filing was addressed to both BSE Limited, located at P.J. Towers, Dalal Street, Fort, Mumbai-400 001 (BSE scrip code: 543635), and National Stock Exchange of India Limited, situated at Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai-400 051 (NSE symbol: PPLPHARMA). The document was digitally signed by Vivek Valsaraj on April 29, 2026, at 15:43:52 +05'30'.
Vivek Valsaraj holds the position of Whole-Time Director and Chief Financial Officer at Piramal Pharma Limited. The submission was made to ensure that the stock exchanges have updated contact information for the company's Key Managerial Personnel for regulatory compliance purposes.
Historical Stock Returns for Piramal Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.07% | +5.24% | +12.75% | -20.70% | -23.63% | -12.76% |
What strategic initiatives might Piramal Pharma announce in the coming quarters that would require enhanced regulatory communication channels?
How could the updated KMP contact framework impact Piramal Pharma's ability to execute time-sensitive corporate actions or M&A activities?
Will Piramal Pharma's strengthened regulatory compliance infrastructure support potential expansion into new international markets?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
